Literature DB >> 25008297

Implication of SUMO E3 ligases in nucleotide excision repair.

Maasa Tsuge1, Hidenori Kaneoka, Yusuke Masuda, Hiroki Ito, Katsuhide Miyake, Shinji Iijima.   

Abstract

Post-translational modifications alter protein function to mediate complex hierarchical regulatory processes that are crucial to eukaryotic cellular function. The small ubiquitin-like modifier (SUMO) is an important post-translational modification that affects transcriptional regulation, nuclear localization, and the maintenance of genome stability. Nucleotide excision repair (NER) is a very versatile DNA repair system that is essential for protection against ultraviolet (UV) irradiation. The deficiencies in NER function remarkably increase the risk of skin cancer. Recent studies have shown that several NER factors are SUMOylated, which influences repair efficiency. However, how SUMOylation modulates NER has not yet been elucidated. In the present study, we performed RNAi knockdown of SUMO E3 ligases and found that, in addition to PIASy, the polycomb protein Pc2 affected the repair of cyclobutane pyrimidine dimers. PIAS1 affected both the removal of 6-4 pyrimidine pyrimidone photoproducts and cyclobutane pyrimidine dimers, whereas other SUMO E3 ligases did not affect the removal of either UV lesion.

Entities:  

Year:  2014        PMID: 25008297      PMCID: PMC4474995          DOI: 10.1007/s10616-014-9762-8

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  30 in total

1.  SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting.

Authors:  M S Rodriguez; C Dargemont; R T Hay
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

Review 2.  Protein modification by SUMO.

Authors:  Erica S Johnson
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

Review 3.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

Review 4.  Principles of ubiquitin and SUMO modifications in DNA repair.

Authors:  Steven Bergink; Stefan Jentsch
Journal:  Nature       Date:  2009-03-26       Impact factor: 49.962

5.  UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex.

Authors:  Kaoru Sugasawa; Yuki Okuda; Masafumi Saijo; Ryotaro Nishi; Noriyuki Matsuda; Gilbert Chu; Toshio Mori; Shigenori Iwai; Keiji Tanaka; Kiyoji Tanaka; Fumio Hanaoka
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

Review 6.  The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.

Authors:  Jaclyn R Gareau; Christopher D Lima
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12       Impact factor: 94.444

7.  DNA damage triggers nucleotide excision repair-dependent monoubiquitylation of histone H2A.

Authors:  Steven Bergink; Florian A Salomons; Deborah Hoogstraten; Tom A M Groothuis; Harm de Waard; Junxin Wu; Li Yuan; Elisabetta Citterio; Adriaan B Houtsmuller; Jacques Neefjes; Jan H J Hoeijmakers; Wim Vermeulen; Nico P Dantuma
Journal:  Genes Dev       Date:  2006-05-15       Impact factor: 11.361

8.  SUMO-dependent regulation of centrin-2.

Authors:  Ulf R Klein; Erich A Nigg
Journal:  J Cell Sci       Date:  2009-08-25       Impact factor: 5.285

9.  In vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene product.

Authors:  Maureen E Fitch; Satoshi Nakajima; Akira Yasui; James M Ford
Journal:  J Biol Chem       Date:  2003-08-27       Impact factor: 5.157

10.  SUMO: regulating the regulator.

Authors:  Guillaume Bossis; Frauke Melchior
Journal:  Cell Div       Date:  2006-06-29       Impact factor: 5.130

View more
  1 in total

1.  PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target.

Authors:  Holger Hans Hermann Erb; Marlies Ebert; Ronja Kuhn; Lukas Donix; Axel Haferkamp; Robert Ian Seed; Eva Jüngel
Journal:  PLoS One       Date:  2019-10-22       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.